Table 1 Baseline characteristics

From: Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation

Characteristic

N = 3817

Age, years

71 ± 10

Female sex

1067 (28)

Body mass index, kg/m2

27 ± 5

Systolic blood pressure, mmHg

134 ± 19

Heart rate, bpm

70 ± 17

CHA2DS2-VASc score

3.2 ± 1.7

Smoking status

 Active

298 (8)

 Past

1836 (48)

 Never

1673 (44)

Type of atrial fibrillation

 Paroxysmal

1869 (49)

 Persistent

1070 (28)

 Permanent

875 (23)

Medical history

 Hypertension

2635 (69)

 Diabetes

614 (16)

 Prior stroke/TIA

651 (17)

 Coronary artery disease

1021 (27)

 Prior myocardial infarction

564 (15)

 Peripheral vascular disease

281 (7)

 Heart failure

909 (24)

 Major bleeding

146 (4)

 Chronic kidney disease

708 (19)

Oral anticoagulation

3212 (84)

 Direct oral anticoagulants

1346 (35)

 Vitamin K antagonists

1864 (49)

  1. Data are presented as means ± standard deviations or counts (percentages).
  2. TIA transient ischemic attack.